Skip to main content

HUSSMAN STRATEGIC ADVISORS, INC.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1179475 ELLICOTT CITY, MD

Position in HALO

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$3,393,075
-$140,175 QoQ
Shares Held
52,500
0.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

HUSSMAN STRATEGIC ADVISORS, INC. holds $44,137,764 across 23 Biotechnology names. HALO ranks #4 (7.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 HALO
Halozyme Therapeutics, Inc.
This page
52,500 $3,393,075

All Filings in HALO

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,393,075 52,500
2025-12-31 $3,533,250 52,500
2025-09-30 $2,310,210 31,500
2025-06-30 $4,369,680 84,000
2025-03-31 $4,690,035 73,500
2024-12-31 $3,514,035 73,500
2024-09-30 $2,404,080 42,000
2024-06-30 $2,199,120 42,000
2024-03-31 $1,281,420 31,500
2023-12-31 $1,164,240 31,500
2023-09-30 $1,203,300 31,500
2023-06-30 $1,677,255 46,500
2023-03-31 $1,775,835 46,500
2022-12-31 $1,411,120 24,800
2022-09-30 $1,225,740 31,000
2022-06-30 $409,200 9,300